
Featured Therapy
SPRAVATO® (esketamine) CIII Nasal Spray is the only FDA-approved treatment used as monotherapy or in conjunction with an oral antidepressant for adults with treatment-resistant depression and for depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior in conjunction with an oral antidepressant.


ABILIFY MAINTENA® (aripiprazole) and ABILIFY ASIMTUFII® (aripiprazole) are monthly* maintenance treatments for schizophrenia and monotherapy in bipolar I disorder in adults. *timing and dosage depends on your diagnosis.
Learn MoreARIsTADA® (aripiprazole lauroxil) is a long-acting injectable medication used to treat adults with schizophrenia after patient has received an initial injection of Aristado Initio and oral aripiprazole supplementation.
Learn MoreBRIXADI (Buprenorphine (Extended-Release Injection)) is a long-acting injection that contains buprenorphine. Buprenorphine has been used to treat opioid use disorder (OUD) for many years.
Learn MoreFluphenazine (floo-FEN-a-zeen) injectable is a antipsychotic medicine that is used primarily as maintenance therapy for chronic schizophrenia and related psychotic disorders in patients who do not tolerate oral formulations or in patients where medication compliance is a concern of the provider.
Learn MoreHaldol Decanoate (haloperidol decanoate) is a first-generation long-acting injectable antipsychotic medication used to treat schizophrenia, specifically for patients who require prolonged antipsychotic therapy.
Learn MoreINVEGA® (paliperidone) is an extended-release injection indicated for the treatment of schizophrenia. and schizoaffective disorder, this injection helps reduce symptoms like paranoia or disorganized thinking.
Learn MoreSPRAVATO® (esketamine) CIII Nasal Spray is the only FDA-approved treatment used as monotherapy or in conjunction with an oral antidepressant for adults with treatment-resistant depression and for depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior in conjunction with an oral antidepressant.
Learn MoreSUBLOCADE® (buprenorphine extended-release) is a long-acting, once-monthly injectable medication containing buprenorphine, used to treat adults with moderate-to-severe opioid use disorder. It is administered by a healthcare professional as part of a comprehensive treatment plan that includes counseling and psychosocial support.
Learn MoreUZEDY® (risperidone) is a long-acting injectable medication used to treat adults with schizophrenia and bipolar I disorder.
Learn MoreVIVITROL (Naltrexone (Extended-Release Injection) is a prescription injectable medicine used to treat adults with alcohol dependence and opioid dependence, after opioid detoxification.
Learn MoreZyprexa Relprevv (Olanszapine Pamoate) treats schizophrenia and bipolar disorder.
Learn MoreBook an appointment with us to start your journey with Sage Elevate!